PhRMA Presses Case For Dumping 340B Orphan Drug Rule
Pharmaceutical Research and Manufacturers of America is once again pushing a D.C. federal court to nix a U.S. Department of Health and Human Services interpretative rule on discounts for orphan drugs...To view the full article, register now.
Already a subscriber? Click here to view full article